新型冠状病毒感染对哮喘儿童肺功能影响

doi:10.12372/jcp.2022.23e0163

Abstract

Abstract:

The pandemic of COVID-19 raises new challenges in the management of pediatric asthma. We analyzed airway injury in children with asthma from molecular mechanism to pathological alterations and explored the effect of SARS-CoV-2 on pulmonary function, which will inform clinicians in the diagnosis and management of childhood asthma in the context of the new coronavirus epidemic.

Key words: respiratory virus, SARS-CoV-2, lung function, bronchial asthma, child

WANG Jinrong, MIAO Yu, MA Guangzeng, CAO Luofei. Effect of SARS-CoV-2 infection on pulmonary function in children with asthma[J].Journal of Clinical Pediatrics, 2023, 41(5): 333-338.

References 44

[1]	World Health Organization. WHO Coronavirus (COVID-19)[EB/OL]. [2022-02-25]. https://covid19.who.int.
[2]	No authors listed. The global asthma report 2022[J]. Int J Tuberc Lung Dis, 2022, 26(1): 1-104.
[3]	Campos C, Prokopich S, Loewen H, et al. Long-term effect of COVID-19 on lung imaging and function, cardiorespiratory symptoms, fatigue, exercise capacity, and functional capacity in children and adolescents: a systematic review and meta-analysis[J]. Healthcare (Basel), 2022, 10(12): 2492.
[4]	Seibold MA, Moore CM, Everman JL, et al. Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: a prospective surveillance study[J]. J Allergy Clin Immunol, 2022, 150(2): 302-311. doi: 10.1016/j.jaci.2022.05.014 pmid: 35660376
[5]	Kompaniyets L, Agathis NT, Nelson JM, et al. Underlying medical conditions associated with severe COVID-19 illness among children[J]. JAMA Netw Open, 2021, 4(6): e2111182. doi: 10.1001/jamanetworkopen.2021.11182
[6]	Shi T, Pan J, Katikireddi SV, et al. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study[J]. Lancet Respir Med, 2022, 10: 191-198. doi: 10.1016/S2213-2600(21)00491-4
[7]	Chiang CY, Ellwood P, Ellwood E, et al. Infection with SARS-CoV-2 among children with asthma: evidence from Global Asthma Network[J]. Pediatr Allergy Immunol, 2022, 33(1): e13709.
[8]	Pivniouk V, Pivniouk O, DeVries A, et al. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression[J]. J Allergy Clin Immunol, 2022, 149(3): 923-933.. doi: 10.1016/j.jaci.2021.11.019
[9]	Tay MZ, Poh CM, Rénia L, et al. The trinity of COVID-19: immunity, inflammation and intervention[J]. Nat Rev Immunol, 2020, 20(6): 363-374. doi: 10.1038/s41577-020-0311-8 pmid: 32346093
[10]	Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19[J]. Nat Rev Immunol, 2021, 21(11): 694-703. doi: 10.1038/s41577-021-00588-x pmid: 34373622
[11]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet (London, England), 2020, 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
[12]	Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning[J]. Autoimmun Rev, 2020, 19(6): 102538. doi: 10.1016/j.autrev.2020.102538
[13]	Zhao L, Zhang YP, Yang X, et al. Eosinopenia is associated with greater severity in patients with coronavirus disease 2019[J]. Allergy, 2021, 76: 562-564. doi: 10.1111/all.v76.2
[14]	Crook H, Raza S, Nowell J, et al. Long covid-mechanisms, risk factors, and management[J]. BMJ, 2021, 374: n1648.
[15]	Cui S, Chen S, Li X, et al. Prevalence of venous throm-boembolism in patients with severe novel coronavirus pneumonia[J]. J Thromb Haemost, 2020, 18(6): 1421-1424. doi: 10.1111/jth.14830
[16]	Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis[J]. Pulmonology, 2021, 27: 328-337. doi: 10.1016/j.pulmoe.2020.10.013
[17]	Öztürk GK, Beken B, Doğan S, et al. Pulmonary function tests in the follow-up of children with COVID-19[J]. Eur J Pediatr, 2022, 181: 2839-2847. doi: 10.1007/s00431-022-04493-w pmid: 35522314
[18]	Soyak Aytekin E, Sahiner UM, Tuten Dal S, et al. Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma[J]. Pediatr Pulmonol, 2022, 57: 1668-1676. doi: 10.1002/ppul.v57.7
[19]	Choudhary S, Sharma K, Silakari O. The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options[J]. Microb Pathog, 2021, 150: 104673. doi: 10.1016/j.micpath.2020.104673
[20]	D'Agnillo F, Walters KA, Xiao Y, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19[J]. Sci Transl Med, 2021, 13: eabj7790. doi: 10.1126/scitranslmed.abj7790
[21]	Du X, Yang Y, Yang Mg et al. ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells[J]. Int J Biol Sci, 2022, 18: 349-359. doi: 10.7150/ijbs.66215 pmid: 34975337
[22]	Sajuthi SP, DeFord P, Li Y, et al. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium[J]. Nat Commun, 2020, 11(1): 5139. doi: 10.1038/s41467-020-18781-2 pmid: 33046696
[23]	Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study[J]. Lancet Respir Med, 2019, 7(5): 402-416. doi: 10.1016/S2213-2600(19)30049-9 pmid: 30876830
[24]	Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, et al. Long COVID in children: observations from a designated pediatric clinic[J]. Pediatr Infect Dis J, 2021, 40: e509-e511. doi: 10.1097/INF.0000000000003285 pmid: 34371507
[25]	Maniscalco M, Ambrosino P, Fuschillo S, et al. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation[J]. Respir Med, 2021, 182: 106401. doi: 10.1016/j.rmed.2021.106401
[26]	Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020, 8(4): 420-422. doi: 10.1016/S2213-2600(20)30076-X pmid: 32085846
[27]	国家儿童医学中心, 首都医科大学附属北京儿童医院新型冠状病毒感染重症救治专家组, 北京儿童新型冠状病毒感染医疗救治市级专家组. 儿童新型冠状病毒Omicron变异株感染重症早期识别和诊治建议[J]. 中华儿科杂志, 2023, 61(3): 199-202.
[28]	Faverio P, Luppi F, Rebora P, et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicentre follow-up study[J]. Respiration, 2021, 100: 1078-1087. doi: 10.1159/000518141
[29]	Xu C, Ma M, Yi Y, et al. Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019[J]. Ann Med, 2022, 54(1): 2391-2401. doi: 10.1080/07853890.2022.2114608 pmid: 36039499
[30]	Long ME, Mallampalli RK, Horowitz JC. Pathogenesis of pneumonia and acute lung injury[J]. Clin Sci (Lond), 2022, 136(10): 747-769. doi: 10.1042/CS20210879 pmid: 35621124
[31]	Heiss R, Tan L, Schmidt S, et al. Pulmonary dysfunction after pediatric COVID-19[J]. Radiology, 2023, 306(3): e221250. doi: 10.1148/radiol.221250
[32]	Camporota L, Cronin JN, Busana M, et al. Pathophysiology of coronavirus-19 disease acute lung injury[J]. Curr Opin Crit Care e, 2022, 28(1): 9-16.
[33]	Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma[J]. J Allergy Clin Immunol, 2011, 128(3): 549-556. doi: 10.1016/j.jaci.2011.05.038 pmid: 21752437
[34]	Bajbouj K, Ramakrishnan RK, Hamid Q. Role of matrix metalloproteinases in angiogenesis and its implications in asthma[J]. J Immunol Res, 2021: 6645072.
[35]	Lee KS, Min KH, Kim SR, et al. Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma[J]. Am J Respir Crit Care Med, 2006, 174(2): 161-170. doi: 10.1164/rccm.200510-1558OC
[36]	Lucas C, Wong P, Klein J, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19[J]. Nature, 2020, 584(7821): 463-469. doi: 10.1038/s41586-020-2588-y
[37]	Pathinayake PS, Awatade NT, Wark PAB. Type 2 immunity and its impact on COVID-19 infection in the airways[J]. Viruses, 2023, 15(2): 402. doi: 10.3390/v15020402
[38]	Roberts LM, Jessop F, Wehrly TD, et al. CuttinG EDGE: LUNG-RESident T cells elicited by SARS-CoV-2 do not mediate protection against secondary infection[J]. J Immunol, 2021, 207(10): 2399-404. doi: 10.4049/jimmunol.2100608 pmid: 34607940
[39]	Rahimi RA, Nepal K, Cetinbas M, et al. Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease[J]. J Exp Med, 2020, 217(9) : e20190865.
[40]	May BC, Gallivan KH. Levocetirizine and montelukast in the COVID-19 treatment paradigm[J]. Int Immu-nopharmacol, 2022, 103: 108412.
[41]	Mera-Cordero F, Bonet-Monne S, Almeda-Ortega J, et al. Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol[J]. Trials, 2022, 23(1): 19. doi: 10.1186/s13063-021-05951-w pmid: 34991703
[42]	Zhang L, Wang X, Huang Y, et al. Pediatric asthma situation in Chengdu, China, during the COVID-19 pandemic: an observational study[J]. J Asthma Allergy, 2021, 14: 829-838. doi: 10.2147/JAA.S315695 pmid: 34276218
[43]	Borg Bm, Osadnik C, Adam K, et al. Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement[J]. Respirology, 2022, 27(9): 688-719. doi: 10.1111/resp.14340 pmid: 35981737
[44]	Franczuk M, Przybyłowski T, Czajkowska-Malinowska M, et al. Spirometry during the SARS-CoV-2 pandemic. Guidelines and practical advice from the expert panel of Respiratory Physiopathology Assembly of Polish Respiratory Society[J]. Adv Respir Med, 2020, 88(6): 640-650. doi: 10.5603/ARM.a2020.0186 pmid: 33393664

Effect of SARS-CoV-2 infection on pulmonary function in children with asthma

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28.
[2]	LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34.
[3]	ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55.
[4]	JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13.
[5]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[6]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[7]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[8]	ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804.
[9]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[10]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[11]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[12]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[13]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[14]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[15]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.